Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma ; volume:27 ; number:9 ; day:18 ; month:7 ; year:2013 ; pages:839-846 ; date:11.2013
Annals of nuclear medicine ; 27, Heft 9 (18.7.2013), 839-846, 11.2013
- Urheber
-
Wakabayashi, Hiroshi
Taki, Junichi
Inaki, Anri
Nakamura, Ayane
Kayano, Daiki
Fukuoka, Makoto
Matsuo, Shinro
Nakajima, Kenichi
Kinuya, Seigo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12149-013-0755-z
- URN
-
urn:nbn:de:101:1-2021081618574139093797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wakabayashi, Hiroshi
- Taki, Junichi
- Inaki, Anri
- Nakamura, Ayane
- Kayano, Daiki
- Fukuoka, Makoto
- Matsuo, Shinro
- Nakajima, Kenichi
- Kinuya, Seigo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations